Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thu, 10/21/10 - 11:07 am
Amylin
diabetes
Alkermes
Eli Lilly
Bydureon
Five Stocks Keeping Company With Viagra
Seeking Alpha
Thu, 10/21/10 - 10:51 am
erectile dysfunction
Viagra
GSK
Eli Lilly
Merck
Pfizer
Bayer AG
Eli Lilly Net Rises 38% on Cost Cuts
TheStreet.com
Thu, 10/21/10 - 10:50 am
Eli Lilly
earnings
Lilly, MacroGenics Say Diabetes Treatment Misses Goal in Late-Stage Study
Bloomberg
Wed, 10/20/10 - 09:38 pm
diabetes
Macrogenics
Eli Lilly
teplizumab
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wed, 10/20/10 - 10:46 am
Amylin
Eli Lilly
Alkermes
FDA
Bydureon
diabetes
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Eli Lilly
M&A
Amylin
Bydureon
diabetes
Alkermes
Alkermes' Drug Approval On Tap
Investors.com
Tue, 10/19/10 - 10:28 pm
Alkermes
FDA
Bydureon
diabetes
Eli Lilly
Amylin
Byetta
Vivitrol
alcoholism
Lilly, Novo tops among diabetes doctors
Fierce Pharma
Tue, 10/19/10 - 06:48 pm
Eli Lilly
Novo Nordisk
diabetes
physicians
Doc-payment database details industry ties
Fierce Pharma
Tue, 10/19/10 - 11:39 am
physician payments
GSK
AstraZeneca
Eli Lilly
Merck
Pfizer
JNJ
Cephalon
Lilly osteoporosis drug regrows jaw bone: study
Reuters, UK
Mon, 10/18/10 - 10:28 am
Eli Lilly
osteoporosis
Forteo
Analyzing Major Big Pharma Players Using Relative Valuation
Seeking Alpha
Mon, 10/18/10 - 10:07 am
Abbott Laboratories
Bristol-Myers Squibb
GSK
Eli Lilly
Merck
Novartis
Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
Seeking Alpha
Sun, 10/17/10 - 11:57 am
Eli Lilly
Alimta
squamous cell cancer
head and neck cancer
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
With Meridia Gone, Can’t We Just Admit There’s No Money in Diet Drugs?
BNET Pharma
Mon, 10/11/10 - 05:55 pm
Meridia
diet drugs
Abbott Laboratories
GSK
Roche
Allergan
Novo Nordisk
Sanofi
Merck
Eli Lilly
Amylin
Takeda
Orexigen
Lilly drops Alimta in head/neck cancer, test fails
Reuters
Mon, 10/11/10 - 11:15 am
head and neck cancer
Eli Lilly
Alimta
Merck KGaA’s Erbitux Delays Progression of Breast Cancer in Test
Bloomberg
Mon, 10/11/10 - 10:48 am
Merck KGaA
Erbitux
Eli Lilly
breast cancer
Incyte Pharmaceuticals’ JAK: Just Another Kinase?
Seeking Alpha
Tue, 10/5/10 - 08:44 pm
Incyte
Kinase
AstraZeneca
Eli Lilly
Sanofi
Janus kinase
Big Pharma behaving badly: A timeline of settlements
Fierce Pharma
Tue, 10/5/10 - 11:09 am
settlements
Novartis
Forest Labs
Allergan
Elan
JNJ
AstraZeneca
Abbott Laboratories
Eli Lilly
Merck
GSK
Pfizer
Sanofi
Drugmakers Probed by Regulators on Global Bribery Allegations, WSJ Reports
Bloomberg
Tue, 10/5/10 - 07:02 am
bribery
Merck
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
SciClone
Baxter International
Antipsychotics, Illegal Marketing And Lawsuits
NY Times, NY
Mon, 10/4/10 - 10:00 am
lawsuits
antipsychotics
JNJ
AstraZeneca
Eli Lilly
Pfizer
Bristol-Myers Squibb
Pages
« first
‹ previous
…
121
122
123
124
125
126
127
128
129
…
next ›
last »